Change Control & Revalidation

Future Trends: Digital QMS, CSA and Analytics-Driven Requalification & Periodic Review

Posted on By digi

Future Trends: Digital QMS, CSA and Analytics-Driven Requalification & Periodic Review Future Trends: Digital QMS, CSA and Analytics-Driven Requalification & Periodic Review Clinical trials have continuously evolved to meet the growing demands of efficiency, transparency, and compliance in the research landscape. The integration of digital Quality Management Systems (QMS), Computerized Systems Assurance (CSA), and analytics-driven…

Read More “Future Trends: Digital QMS, CSA and Analytics-Driven Requalification & Periodic Review” »

Requalification & Periodic Review

How Requalification & Periodic Review Supports Regulatory Filings and Post-Approval Changes

Posted on By digi

How Requalification & Periodic Review Supports Regulatory Filings and Post-Approval Changes How Requalification & Periodic Review Supports Regulatory Filings and Post-Approval Changes In the complex landscape of clinical trials, regulatory compliance remains paramount. One crucial aspect of maintaining compliance is the process of requalification and periodic review. This guide aims to provide clinical operations, regulatory…

Read More “How Requalification & Periodic Review Supports Regulatory Filings and Post-Approval Changes” »

Requalification & Periodic Review

Documentation, TMF/QMS Alignment and Audit Trails for Requalification & Periodic Review

Posted on By digi

Documentation, TMF/QMS Alignment and Audit Trails for Requalification & Periodic Review Documentation, TMF/QMS Alignment and Audit Trails for Requalification & Periodic Review The management of clinical trials requires meticulous attention to detail, especially when addressing requalification and periodic reviews as part of change control practices. The alignment of documentation, Trial Master File (TMF), and Quality…

Read More “Documentation, TMF/QMS Alignment and Audit Trails for Requalification & Periodic Review” »

Requalification & Periodic Review

Training and Change Management to Embed Requalification & Periodic Review in the Organization

Posted on By digi

Training and Change Management to Embed Requalification & Periodic Review in the Organization Training and Change Management to Embed Requalification & Periodic Review in the Organization Introduction to Requalification and Periodic Review in Clinical Trials Requalification and periodic reviews are critical components in the maintenance of Good Clinical Practice (GCP) compliance in clinical trials. The…

Read More “Training and Change Management to Embed Requalification & Periodic Review in the Organization” »

Requalification & Periodic Review

Vendor and Partner Oversight Considerations in Requalification & Periodic Review

Posted on By digi

Vendor and Partner Oversight Considerations in Requalification & Periodic Review Vendor and Partner Oversight Considerations in Requalification & Periodic Review The ongoing complexity of clinical trial systems necessitates that clinical research professionals remain vigilant regarding vendor and partner oversight, particularly in the context of requalification and periodic review processes. As clinical operations, regulatory affairs, and…

Read More “Vendor and Partner Oversight Considerations in Requalification & Periodic Review” »

Requalification & Periodic Review

Aligning Regulatory Notifications & Filings With Risk Management, CAPA and QMS Requirements

Posted on By digi

Aligning Regulatory Notifications & Filings With Risk Management, CAPA and QMS Requirements In the highly regulated environment of clinical trials, especially precision medicine clinical trials, alignment of regulatory notifications and filings with Quality Management System (QMS) requirements, Corrective and Preventive Actions (CAPA), and overall risk management is paramount. This tutorial provides a comprehensive, step-by-step guide…

Read More “Aligning Regulatory Notifications & Filings With Risk Management, CAPA and QMS Requirements” »

Regulatory Notifications & Filings

Common Pitfalls in Regulatory Notifications & Filings—and How to Avoid Compliance Findings

Posted on By digi

Common Pitfalls in Regulatory Notifications & Filings—and How to Avoid Compliance Findings Common Pitfalls in Regulatory Notifications & Filings—and How to Avoid Compliance Findings Regulatory notifications and filings are critical components of clinical trials, ensuring that sponsors and investigators remain compliant with Good Clinical Practice (GCP) and regulatory requirements. In this guide, we will explore…

Read More “Common Pitfalls in Regulatory Notifications & Filings—and How to Avoid Compliance Findings” »

Regulatory Notifications & Filings

Regulatory Notifications & Filings in Practice: Step-by-Step Guide for QA and Clinical Teams

Posted on By digi

Regulatory Notifications & Filings in Practice: Step-by-Step Guide for QA and Clinical Teams Regulatory Notifications & Filings in Practice: Step-by-Step Guide for QA and Clinical Teams In the realm of clinical trials, regulatory notifications and filings are critical processes that ensure compliance with Good Clinical Practice (GCP), regulatory standards, and the integrity of clinical research…

Read More “Regulatory Notifications & Filings in Practice: Step-by-Step Guide for QA and Clinical Teams” »

Regulatory Notifications & Filings

How to Design Regulatory Notifications & Filings That Survives FDA, EMA and MHRA Inspections

Posted on By digi

How to Design Regulatory Notifications & Filings That Survives FDA, EMA and MHRA Inspections Designing regulatory notifications and filings in the clinical research domain is a multidimensional process entailing precise adherence to Good Clinical Practice (GCP) guidelines and ensuring compliance with regulatory bodies such as the FDA, EMA, and MHRA. This comprehensive guide offers a…

Read More “How to Design Regulatory Notifications & Filings That Survives FDA, EMA and MHRA Inspections” »

Regulatory Notifications & Filings

Regulatory Notifications & Filings: End-to-End Framework for GxP-Regulated Environments

Posted on By digi

Regulatory Notifications & Filings: End-to-End Framework for GxP-Regulated Environments Regulatory Notifications & Filings: End-to-End Framework for GxP-Regulated Environments Understanding Regulatory Notifications and Filings in GxP Environments In the context of Good Practice (GxP) regulations, understanding the framework for regulatory notifications and filings is critical for clinical trial services. GxP encompasses a range of regulations and…

Read More “Regulatory Notifications & Filings: End-to-End Framework for GxP-Regulated Environments” »

Regulatory Notifications & Filings